List of Tables
    Table 1. Anti-tuberculosis Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Anti-tuberculosis Therapeutics Market Drivers in Global Market
    Table 3. Anti-tuberculosis Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Anti-tuberculosis Therapeutics in Global Market
    Table 5. Top Anti-tuberculosis Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Anti-tuberculosis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Anti-tuberculosis Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Anti-tuberculosis Therapeutics Product Type
    Table 9. List of Global Tier 1 Anti-tuberculosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Anti-tuberculosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Anti-tuberculosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Anti-tuberculosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Anti-tuberculosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Anti-tuberculosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Anti-tuberculosis Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Anti-tuberculosis Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Lupin Corporate Summary
    Table 31. Lupin Anti-tuberculosis Therapeutics Product Offerings
    Table 32. Lupin Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Macleods Pharmaceuticals Corporate Summary
    Table 34. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Offerings
    Table 35. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Otsuka Pharmaceutical Corporate Summary
    Table 37. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Offerings
    Table 38. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Anti-tuberculosis Therapeutics Product Offerings
    Table 41. Johnson & Johnson Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Anti-tuberculosis Therapeutics Product Offerings
    Table 44. Pfizer Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Novartis Corporate Summary
    Table 46. Novartis Anti-tuberculosis Therapeutics Product Offerings
    Table 47. Novartis Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Abbott Corporate Summary
    Table 49. Abbott Anti-tuberculosis Therapeutics Product Offerings
    Table 50. Abbott Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Anti-tuberculosis Therapeutics Product Offerings
    Table 53. AstraZeneca Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Bayer Corporate Summary
    Table 55. Bayer Anti-tuberculosis Therapeutics Product Offerings
    Table 56. Bayer Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Eli Lilly Corporate Summary
    Table 58. Eli Lilly Anti-tuberculosis Therapeutics Product Offerings
    Table 59. Eli Lilly Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 60. GlaxoSmithKline Corporate Summary
    Table 61. GlaxoSmithKline Anti-tuberculosis Therapeutics Product Offerings
    Table 62. GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 63. Merck Corporate Summary
    Table 64. Merck Anti-tuberculosis Therapeutics Product Offerings
    Table 65. Merck Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 66. Sanofi Corporate Summary
    Table 67. Sanofi Anti-tuberculosis Therapeutics Product Offerings
    Table 68. Sanofi Anti-tuberculosis Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Anti-tuberculosis Therapeutics Segment by Type in 2021
    Figure 2. Anti-tuberculosis Therapeutics Segment by Application in 2021
    Figure 3. Global Anti-tuberculosis Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Anti-tuberculosis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Anti-tuberculosis Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2021
    Figure 8. By Type - Global Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Anti-tuberculosis Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Anti-tuberculosis Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Lupin Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Novartis Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Abbott Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bayer Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Eli Lilly Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Merck Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Sanofi Anti-tuberculosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)